<DOC>
	<DOCNO>NCT00075855</DOCNO>
	<brief_summary>RATIONALE : The hormone testosterone may improve libido ( sex drive ) woman . It yet know whether testosterone effective improve libido female cancer survivor . PURPOSE : This randomized phase III trial study well low-dose testosterone work improve libido postmenopausal cancer survivor .</brief_summary>
	<brief_title>Low-Dose Testosterone Improving Libido Postmenopausal Female Cancer Survivors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine efficacy low-dose testosterone , term average intra-patient change libido , postmenopausal female cancer survivor decrease libido . Secondary - Determine toxic effect drug patient . - Determine level estrogen testosterone SGOT patient report decreased libido treatment drug . - Determine whether increase libido significantly positively affect pleasure sexual activity patient treat drug . - Determine effect drug vitality , general quality life , overall mood patient . OUTLINE : This double-blind , placebo-controlled , randomize , crossover , multicenter study . Patients stratify accord antidepressant medication use ( yes v ) , age ( 50 vs 50 60 v 61 70 v 70 ) , tamoxifen selective estrogen receptor modulator use ( yes v ) , ovarian status ( place [ natural menopause hysterectomy ] v place [ bilateral oophorectomy ] ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive topical testosterone daily 4 week . - Arm II : Patients receive topical placebo daily 4 week . After 4 week , patient cross treatment arm . Changes sexual functioning , mood state , medical outcome vitality assess baseline end week 4 8 . Patients continue restart testosterone cream 8-week study period follow 6 month .</detailed_description>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : History cancer No active disease Currently sexual partner Reports decrease sexual desire libido would like intervention Defined score less 8 numerical analogue scale PATIENT CHARACTERISTICS : Age See Menopausal status Sex Female Menopausal status Postmenopausal , define follow : Surgically induce menopause OR absence period least 12 month ( naturally treatmentinduced ) Performance status ECOG 01 Hematopoietic WBC ≥ 2,500/mm^3 Platelet count ≥ 100,000/mm^3 Hemoglobin ≥ 10 g/dL No untreated anemia Hepatic SGOT ≤ 1.5 time upper limit normal ( ULN ) No know liver disease Renal Creatinine ≤ 1.5 time ULN No renal dysfunction Cardiovascular No coronary artery disease No congestive heart failure Other No untreated hypothyroidism No diabetes No major depressive disorder require treatment PRIOR CONCURRENT THERAPY : Chemotherapy Concurrent cytotoxic chemotherapy ( e.g. , tamoxifen aromatase inhibitor ) allow Endocrine therapy No prior testosterone No prior androgen agent libido Concurrent selective estrogen receptor modulators allow Concurrent vaginal estrogen allow provide initiated ≥ 1 month ago continue dose study participation Radiotherapy Concurrent radiotherapy allow Surgery No prior major pelvic surgery result anatomical change vaginal anatomy Prior hysterectomy allow Other Concurrent antidepressant postmenopausal mood hot flash allow provided patient stable dose change within next 8 week No concurrent anticoagulants propanolol Concurrent anticoagulant central peripheral line maintenance ( e.g. , warfarin 1 mg daily heparin flush ) allow No concurrent treatment decrease libido</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>sexual dysfunction</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>sexuality reproductive issue</keyword>
	<keyword>cancer survivor</keyword>
</DOC>